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Decellularized-organ-derived extracellular matrix (dECM) has been used for many years
in tissue engineering and regenerative medicine. The manufacturing of hydrogels
from dECM allows to make use of the pro-regenerative properties of the ECM and,
simultaneously, to shape the material in any necessary way. The objective of the
present project was to investigate differences between cardiovascular tissues (left
ventricle, mitral valve, and aorta) with respect to generating dECM hydrogels and their
interaction with cells in 2D and 3D. The left ventricle, mitral valve, and aorta of porcine
hearts were decellularized using a series of detergent treatments (SDS, Triton-X 100
and deoxycholate). Mass spectrometry-based proteomics yielded the ECM proteins
composition of the dECM. The dECMwas digested with pepsin and resuspended in PBS
(pH 7.4). Upon warming to 37◦C, the suspension turns into a gel. Hydrogel stiffness was
determined for samples with a dECM concentration of 20mg/mL. Adipose tissue-derived
stromal cells (ASC) and a combination of ASC with human pulmonary microvascular
endothelial cells (HPMVEC) were cultured, respectively, on and in hydrogels to analyze
cellular plasticity in 2D and vascular network formation in 3D. Differentiation of ASC was
induced with 10 ng/mL of TGF-β1 and SM22α used as differentiation marker. 3D vascular
network formation was evaluated with confocal microscopy after immunofluorescent
staining of PECAM-1. In dECM, the most abundant protein was collagen VI for the
left ventricle and mitral valve and elastin for the aorta. The stiffness of the hydrogel
derived from the aorta (6,998 ± 895Pa) was significantly higher than those derived
from the left ventricle (3,384 ± 698Pa) and the mitral valve (3,233 ± 323Pa) (One-way
ANOVA, p = 0.0008). Aorta-derived dECM hydrogel drove non-induced (without
TGF-β1) differentiation, while hydrogels derived from the left ventricle and mitral valve
inhibited TGF-β1-induced differentiation. All hydrogels supported vascular network
formation within 7 days of culture, but ventricular dECM hydrogel demonstrated more
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robust vascular networks, with thicker and longer vascular structures. All the three
main cardiovascular tissues, myocardium, valves, and large arteries, could be used to
fabricate hydrogels from dECM, and these showed an origin-dependent influence on
ASC differentiation and vascular network formation.
Keywords: hydrogels, extracellular matrix proteins, tissue engineering, regenerative medicine, biocompatible
materials, biomimetic materials, tissue scaffolds, tissue decellularization
INTRODUCTION
Decellularized organ-derived extracellular matrix (dECM) has
been used for many years in tissue engineering and regenerative
medicine (Conklin et al., 2002; Dahl et al., 2003; Schenke-Layland
et al., 2003). Decellularization of the extracellular matrix can
be achieved through different physical, chemical or biological
processes, including freeze/thaw cycles, use of organic detergents,
and mild treatment with proteolytic enzymes (Crapo et al.,
2011; Hrebikova et al., 2015; Keane et al., 2015; Leonel et al.,
2017; Kawecki et al., 2018). Commonly, different processes are
combined or used sequentially, so as to decrease the damage
caused by each of them to the extracellular matrix but, at
the same time, to potentiate the decellularization protocol
(Crapo et al., 2011; Kawecki et al., 2018). In dECM, both
the structure and biochemical composition of the original
tissue are largely retained which renders dECM a promising
candidate for cell culture and tissue engineering (Hoshiba et
al., 2010, 2016; Cigliano et al., 2012; Petersen et al., 2012;
Poornejad et al., 2016). Also, regeneration-related processes such
as recruitment of progenitor cells, induction of cell migration
and proliferation, and M2 polarization of in macrophages appear
to occur upon in vivo administration of dECM (Reing et al.,
2009; Agrawal et al., 2011; Brown and Badylak, 2014; Dziki
et al., 2017). In general, the large(r) macromolecules of ECM
such as polysaccharides (glycosaminoglycans and proteoglycans)
as well as constructive proteins (collagens, basement membrane
proteins, and fibronectin to mention a few) remain after
decellularization because of their size and their intermolecular
crosslinks. Smaller ECM constituents such as growth factors,
chemokines, and other small signaling molecules are largely
washed out.
Originally, decellularization of whole organs was intended to
reseed stem cells or parenchymal cells to recreate the organ.
More recently, clinical interest shifted to use dECM, as powder
or as hydrogel, for repair and regeneration purposes of organ
damage more than as replacement therapy (Adam Young et al.,
2011; Wolf et al., 2012; Mercuri et al., 2013; Fu et al., 2016;
Ungerleider et al., 2016; Saldin et al., 2017). Hydrogels derived
from dECM are tuneable with respect to biochemical parameters
via loading with growth factors, stem cells while their physical
parameters such as stiffness and viscoelasticity are tuneable too
(Adam Young et al., 2011; DeQuach et al., 2012; Seif-Naraghi
et al., 2012; Ungerleider et al., 2015; Wu et al., 2015). The use
of 3D bioprinting, though in its infancy with dECM-derived
hydrogels, enables to print predetermined shapes and geometries
of factor and cell-loaded gels.
Traditionally, cardiovascular tissue engineering has focused
on replacement tissue for coronary arteries, cardiac valves as
well as left ventricular myocardium with no definitive success
for any of these three (Singelyn et al., 2009, 2012; Seif-Naraghi
et al., 2010, 2012; Duan et al., 2011; Johnson et al., 2011, 2014;
O’Neill et al., 2013; Grover et al., 2014; Pok et al., 2014; Russo
et al., 2015; Ungerleider et al., 2015, 2016; Kappler et al., 2016;
Stoppel et al., 2016; Wassenaar et al., 2016a,b; Efraim et al., 2017;
Fercana et al., 2017; Jang et al., 2017; Wang et al., 2017; Seo
et al., 2018). Most of these efforts used collagen or single ECM
molecule-based scaffolds besides a host of synthetic polymer
materials. We reasoned that regeneration of damaged specific
cardiac compartments (myocardium, valve, or arteries) would
benefit from the use of dECM hydrogels derived from that same
compartment. In other words, we hypothesized that dECM-
derived hydrogels from myocardium, valves, and aorta would
differ in biological and physical features.
METHODS
An illustrative overview of the methods used for the fabrication
of dECM-derived hydrogels is presented in Figure 1. Detailed
description is described below.
Extracellular Matrix Decellularization and
Characterization
Decellularization Protocol
Porcine hearts (12-week old pigs) were bought from a local
slaughterhouse (Kroon Vlees, Groningen, Netherlands) and
dissected to separate the left myocardial tissue, the mitral valve,
and the aorta. The tissues were washed at room temperature (RT)
in phosphate buffer saline (PBS) and triturated in a commercial
blender until pieces were smaller than 1mm. Following a second
wash in PBS, tissue material was sonicated for 1min at 100%
power, washed a third time and incubated in 0.05% trypsin
(Gibco, Thermo Fisher Scientific, Waltham, USA) in PBS at
37◦C for 3 h under constant shaking. After trypsin treatment,
tissue material was washed again with PBS and frozen at −20◦C
overnight. After thawing, tissue material was incubated in
demineralized water (dH2O) for 3 h and then in saturated
sodium chloride solution (NaCl, 6M) for another 3 h, both
steps at 37◦C while shaking continuously. This followed by
a wash with 70% ethanol for 10min and dH2O for another
10min. Afterwards, tissue material treated with 1% sodium
dodecyl sulfate (SDS) (Sigma-Aldrich, St. Louis, USA) in water
for 12 h, washed three times with dH2O, incubated with 1%
Triton X-100 (Sigma-Aldrich, St. Louis, USA) in water for 12 h,
washed three times with dH2O, incubated with 1% sodium
deoxycholate (Sigma-Aldrich, St. Louis, USA) in water for 12 h
and, again, washed three times with dH2O, all steps while shaking
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FIGURE 1 | Illustrative overview of the methods used to produce hydrogels derived from decellularized extracellular matrix.
continuously. After these detergent treatments, tissue material
was incubated for 24 h with DNAse solution [30µg/ml DNAse
(Worthington Biochemical Corporation, Lakewood, USA),
1.3mM MgSO4, 2mM CaCl2] at 37
◦C and continuous shaking.
After DNAse treatment, the decellularized tissue remainder
i.e., extracellular matrix (dECM) was washed three times with
dH2O and stored at 4
◦C in 1% penicillin/streptomycin
(#15140122, Gibco Invitrogen, Carlsbad, USA) in
sterile PBS.
The dECM characterization was comprised of quantification
of residual nuclei, genomic DNA, histochemical stainings
(Hematoxylin/Eosin and Movat’s Pentachrome), quantification
of GAG contents and identification of proteins by
mass spectrometry.
Residual Nuclei and DNA Quantification
For evaluating residual nuclei, native and dECM samples were
stained with 4′,6-diamidino-2-phenylindole (DAPI) (4µg/ml;
#D9542-5MG, blue; Sigma-Aldrich, St. Louis, USA) and
visualized with an Evos FL fluorescence microscope system
(Thermo Fisher Scientific, Waltham, United States).
To isolate genomic DNA freeze-dried native and dECM
samples (n = 3) were weighed and separated as samples of 10–
15mg in a 1.5mL microfuge tube. Each sample was digested at
55◦C in a solution containing 5 µL proteinase K (#3115828001,
Roche, Basel, Switzerland), 50µL 10% SDS, and 500µL SE-buffer
(75mM NaCl; 25mM EDTA; pH 8.0) overnight. Following the
enzymatic digestion, 222 µL of 6MNaCl and 777 µL chloroform
were added and samples thoroughly shaken on a top-over-top
rotator at room temperature (RT) for 1 h and centrifuged at
10,000 × g at 20◦C for 10min. After centrifugation, the upper
layer was transferred to a new tube, and an equal volume of
ice-cold isopropanol was added and gently mixed until DNA
precipitated (if any). The DNA was collected by centrifugation
at 10,000× g at 4◦C for 15min. The DNA pellet was washed with
0.5mL ice-cold 70% ethanol centrifuged at 10,000× g at 4◦C for
5min. Upon removal of the supernatant, the pellet was left to air-
dry in RT. The DNAwas dissolved in 100µL 10mMTris, 0.1mM
EDTA, pH 8.0 at 55◦C and quantified with NanoDrop equipment
(Thermo Scientific, Hemel Hempstead, United Kingdom).
Histochemical Analysis
For histochemical stainings, samples of native and dECM
were fixed with 4% paraformaldehyde (PFA) in PBS for 1 h,
washed with PBS twice, and embedded in paraffin. Five
micrometer sections were mounted on glass microscope
slides, deparaffinized, stained with Hematoxylin/Eosin (HE)
or Movat’s pentachrome stain, mounted with mounting
medium and visualized with a light microscope (DM IL, Leica
Microsystems, Wetzlar, Germany). All samples were stained
simultaneously to rule out the influence of staining variations
among groups.
GAG Quantification
The concentration of sulfated glycosaminoglycans (sGAG) was
measured using the 1,9-dimethylmethylene blue (DMMB) assay,
according to the protocol of Farndale et al. (1982). Briefly, dECM
samples (n = 3) were weighed and separated as samples of 10–
15mg in a 1.5mL microfuge tube. Each sample was digested at
55◦C in a solution containing 5 µL proteinase K (#3115828001,
Roche, Basel, Switzerland), 50µL 10% SDS, and 500µL SE-buffer
(75mM NaCl; 25mM EDTA; pH 8.0) overnight. After digestion,
DMMB staining solution (10:1 to the initial volume) was added to
the samples and excitation was measured at 525 nm and 595 nm
using a spectrophotometer. A titration curve of serially diluted
chondroitin sulfate C (#C4384-250mg, Sigma-Aldrich, St. Louis,
USA) was used as control.
Mass Spectrometry
Samples (n = 3) of dECM from the three different types
of cardiovascular tissue, resp. the left ventricle, mitral valve,
and aorta, were submitted to mass spectrometry analyses
to determine the protein composition in the decellularized
tissue. Lyophilized dECM was milled to a fine powder and
digested in pepsin (#P6887; >3,200 IU; Sigma-Aldrich, St. Louis,
USA) solution. The digested solution was ultrafiltrated using
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centrifugal filter units (Millipore, Billerica, USA) to remove
undigested tissue debris. Liquid chromatography-tandem mass
spectrometry (LC-MS/MS) analysis was performed using an
integrated system composed of nano-LC (Tempo nano-LC
system, MDS SCIEX, Ontario, Canada) and a Quadrupole-TOF
MS/MS spectrometer (QStar Elite, Applied Biosystems, Foster
City, USA) equipped with a nano-electrospray ionization source
at an ion spray voltage of 2.3 keV. Solutions containing pepsin-
digested protein fragments were injected into the nano-LC-
MS/MS system and then separated on a Zorbax 300SB-C18
capillary column (Agilent Technologies, Palo Alto, USA). The
loaded samples were eluted with a 2–35% gradient of solvent
B for 30min, then a 35–90% gradient for 10min, followed
by 90% solvent B for 5min, and finally 5% solvent B for
15min at a flow rate of 300 nL/min. Solvent A consisted
of water/acetonitrile (98/2 [v/v]) and 0.1% formic acid, and
solvent B consisted of water/acetonitrile (2/98 [v/v]) and 0.1%
formic acid. Data acquisition and processing were performed
with Analyst QS 2.0 software (Applied Biosystems, Foster City,
United States). Generated MS/MS data were compared to the
UniProtKB database for Sus scrofa.
dECM Hydrogels Fabrication and
Characterization
dECM Gelation
For dECM gelation, the decellularized extracellular matrices of
the three cardiovascular tissues were lyophilized and milled to
a fine powder. The resulting dECM powder was digested with
pepsin (#P6887; >3,200 IU; Sigma-Aldrich, St. Louis, USA)
in hydrochloric acid solution (20 mg/mL dECM, 2 mg/mL
pepsin, 0.01M HCl) for 6 h at RT and constant stirring. After
digestion, the solution pH was raised with sodium hydroxide
(1/10 of solution volume, 0.1M NaOH) and the electrolytes
equilibrated with PBS (1/10 of solution volume, 10x PBS).
The resulting solution was stored in liquid form (pre-gel)
at 4◦C or transformed into hydrogel by warming to 37◦C
for 1 h.
Scanning Electron Microscopy of dECM Hydrogels
Hydrogels derived from all the three different tissues
were gelated and freeze-dried in a lyophilizer for 3 days.
Samples were, then, analyzed with a tabletop scanning
electron microscope (SEM, Hitachi TM3000, Hitachi High-
Technologies, Japan). Images were acquired using 5 kV and
100X augmentation. The same settings were used for all the
three specimens.
Biomechanical Properties of dECM Hydrogels
Hydrogels derived from the left ventricle, mitral valve, and
aorta were subjected to compressive loading using a low load
compression tester (LLCT), as described previously with minor
modifications (Sharma et al., 2011; Peterson et al., 2013; Nibourg
et al., 2015). Two hundred microliter of the hydrogel was placed
inside polydimethylsiloxane (PDMS) donut-shaped support on
top of a microscope glass slide, which were both placed on the
load cell. First, gel thickness wasmeasured by letting the stainless-
steel plunger (diameter, 25mm) drop down till it touched the
glass surface; this position was recorded as the bottom of the gel.
Then the gel was placed under the plunger and the top of the gel
was determined, the difference in position between the top and
bottom of the gel was taken as the thickness. Plunger dropped at
a speed of 5 µm/s until it experienced a counterforce of 0.0981N
and this was defined as touch. Next, the gel was deformed by
20% (strain = 0.2) i.e., to 80% of its original thickness within 1 s
(strain rate of 0.2 s−1) and the plunger was kept in this position
for another 100 s. Gel stiffness was determined during the first
second of experiment i.e., while the plunger was deforming
the gel as the slope of the stress-strain curve. During the next
100 s the strain was kept constant (at 0.2) while the stress was
observed to continuously decrease with time [σ (t)]. This stress
relaxation at constant strain is proof that the gels are not elastic
but viscoelasticity in nature. The viscoelastic properties were
determined by dividing the decreasing stress with constant strain
(0.2) to get E(t) (=((t)/0.2). A generalized Maxwell model was fit
to E(t) in the form of Equation (1).






τ3 . . . . . . . . . Eie
−t
τi (1)
Each Maxwell element corresponds to one Eie
−t
τi term in
Equation (1) where i varies from 1 to n. A Maxwell element is
characterized by its modulus i.e., Ei and relaxation time constant
i.e., τi for which it remains active. Model fitting was performed
with the Microsoft Excel 2016 Solver module, imposing positive
values for physical relevance. Fitting started with one Maxwell
element with an addition of a new element until the Chi-square
(error function) kept on decreasing. Each element was assigned
with a relative importance (RIi) within each experiment on the




(E1 + E2 + . . . Ei)
(2)
In order to average replicate measurements and compare
different hydrogels based on their viscoelasticity, each Maxwell
element was assigned to a relaxation time range. Four log scale-
based relaxation time ranges were defined i.e., 0–1 s, 1–10 s,
10–100 s, and 100–1,000 s.
In vitro Influence of dECM Hydrogels on
Mesenchymal and Endothelial Cells in 2D
and 3D Cultures
Adipose Tissue-Derived Stromal Cell Culture and
Differentiation on the dECM Hydrogels
Human ASC were isolated as described previously (Tuin
et al., 2010). Briefly, human abdominal fat was obtained
by liposuction, washed with phosphate-buffered saline (PBS)
and digested enzymatically with 0.1% collagenase A (Roche
Diagnostic, Mannheim, Germany) in PBS with 1% bovine serum
albumin (BSA; Sigma-Aldrich, Boston, USA). The tissue was
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shaken constantly at 37◦C for 2 h. After this, the digested
tissue was mixed with 1% PBS/BSA, filtered, centrifuged and
the cell pellet was resuspended in Dulbecco’s Modified Eagle’s
Medium (DMEM; #12-604F, Lonza, Basel, Switzerland) with
10% fetal bovine serum (FBS; #F0804, Sigma-Aldrich, Missouri,
United States), 1% penicillin/streptomycin (#15140122, Gibco
Invitrogen, Carlsbad, USA), and 1% L-glutamine (#17-605E,
Lonza Biowhittaker, Verviers, Belgium). Cells were cultured at
37◦C in a humidified incubator with 5% CO2. The medium was
refreshed every 2 days. Confluent cells were passed at a ratio
of 1:3.
To assess the influence of hydrogel surfaces on the
proliferation and differentiation of ASCs, wells of 24-well plates
were covered with 200 µL of the pre-gel solutions from the three
different ECM sources and allowed to gelate at 37◦C for 1 h. ASC
(P3 to 5) were seeded at 10,000 cells/cm2 on the dECMhydrogels.
Cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM, Lonza, Verviers, Belgium) supplemented with 10%
fetal bovine serum (FBS) (Thermo Scientific, Hemel Hempstead,
United Kingdom), 1% L-glutamine (Lonza, Verviers, Belgium),
and 1% penicillin/streptomycin (Gibco Invitrogen, Carlsbad,
USA) at 37◦C in a humidified incubator with 5% CO2. As a
control, ASC were seeded on tissue culture plastic in the same
medium and at the same density. Seeded ASCs were stimulated
with 10µg/ml TGFβ-1 (PeproTech, London, United Kingdom)
while non-stimulated cultures served as control. Stimulation
was for 7 days and the medium was refreshed every
2 days.
Cells were washed with PBS and fixed with 2%
paraformaldehyde in PBS for 30min, washed with PBS
twice, permeabilized with 0.5% Triton X-100 in PBS for 15min
and blocked with 1% BSA and 5% donkey serum solution
in PBS for 15min to avoid non-specific binding. Myogenic
differentiation was assessed by staining with rabbit anti-SM22α
primary antibody (1:800; Abcam, Cambridge, United Kingdom)
for 2 h, washing with 0.05% Tween in PBS and detection with
donkey anti-rabbit Alexa Fluor R© 647 secondary antibody (1:800;
red; Abcam, Cambridge, United Kingdom) for 1 h at room
temperature. The cytoskeleton was stained by Phalloidin Alexa
Fluor R© 488 (1:400; green; ThermoFisher, Waltham, USA)
and nuclei were stained with DAPI (4µg/ml; #D9542-5MG,
blue; Sigma-Aldrich, St. Louis, USA). SM22α expression was
calculated by the normalized total cell fluorescence (CTCF)
method as previously described (McCloy et al., 2014; Liguori
et al., 2019), and plotted as the fold-change relative to the non-
stimulated tissue culture plastic control. Briefly, the corrected
total cell fluorescence (CTCF) is calculated as the integrated
density (ID) subtracted of the product between the area covered
by cells (A) and the mean fluorescence of background readings
(B), i.e., CTCF= ID – (A× B).
Vascular Network Formation (VNF) in dECM
Hydrogels
ASC and human pulmonary microvascular endothelial cells
(HPMEC) were co-cultured inside the hydrogels to determine
their 3DVNF potential. The HPMEC [HPMEC-ST1.6R (Krump-
Konvalinkova et al., 2001), kind gift of dr. Unger, Johannes-
Gutenberg University, Mainz, Germany] were seeded on gelatin-
coated plates (1% gelatin solution in PBS) at a density of
35,000 cells/cm2 and cultured until confluency in endothelial
culture medium composed of RPMI-1640 basal medium (#BE04-
558F, Lonza, Basel, Switzerland) with 10% heat-inactivated
fetal bovine serum (FBS; #F0804, Sigma-Aldrich, Missouri,
United States), 1% penicillin/streptomycin (#15140122, Gibco
Invitrogen, Carlsbad, USA), 1% L-glutamine (#17-605E, Lonza
Biowhittaker, Verviers, Belgium), 5 U/mL heparin (LEO
Laboratories Limited, Ballerup, Denmark), and 50 g/mL bovine
brain extract (BBE, in-house preparation). Cells were kept
at 37◦C with a minimum relative humidity of 95% and
5% CO2.
For the determination of 3D VNF, ASC and HPMEC were
seeded inside the three different pre-gels at a final density of 1
× 106 per mL, at an ASC:HMVEC ratio of 1:2. Pre-gels were
prepared as described and adjusted to 1x DMEM by addition
of 1/10th of the volume of 10x DMEM. After pre-gels were
mixed with the cells, 200 µL of the suspension was pipetted
inside wells of an 8-well Chamber SlideTM System (ibidi GmbH,
Gräfelfing, Germany) and incubated at 37◦C for 1 h. Upon
gelation, 200 µL endothelial culture medium was added per
well. Cells were cultured for 7 days and medium refreshed
every 2 days.
After PBS washes, cell-loaded dECM hydrogels were fixed
with 4% PFA in PBS for 1 h, washed with PBS twice, frozen
in liquid nitrogen, cryosections (50µm) were deposited on
microscope slides. Samples were permeabilized with 0.5% Triton
X-100 in PBS for 15min and blocked with 1% BSA and 5%
donkey serum solution in PBS for 15min. To assess 3D VNF,
samples were incubated overnight with rabbit anti-SM22α (1:400;
#ab14106, Abcam, Cambridge, UK) for detection of ASC-derived
pericytes (Hajmousa et al., 2018; Terlizzi et al., 2018) and
mouse anti-human PECAM-1 (1:100, #M0823, Dako, Glostrup,
Denmark) to detect endothelial cells, washed with 0.05% Tween
in PBS and incubated with donkey anti-rabbit IgG (H+L)
Alexa Fluor R© 594 (1:400; #A-21207, Life Technologies, Carlsbad,
United States) and donkey anti-mouse IgG (H+L) Alexa Fluor R©
488 (1:400; #ab150105, Abcam, Cambridge, UK) at RT for
1 h. Nuclei were stained with DAPI (4µg/ml; #D9542-5MG,
Sigma-Aldrich, Missouri, United States). Confocal laser scanning
microscope (TCS SP8, Leica Microsystems, Wetzlar, Germany)
was used to acquire Z-stack images at 20x magnification. 3D
vascular network formation was evaluated qualitatively in 3D
reconstructed images post-processed using ImageJ 3D viewer
plugin, and quantitatively by the fluorescence intensity of
PECAM-1 labeling. In our experience, ASC do not express
PECAM-1 when cultured in the endothelial culture medium,
thus this marker solely visualized vascular-like structures in
our system.
Statistical Analysis
All data were obtained from at least three independent
experiments. Data are presented as the mean ± standard error
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of the mean (SEM). Graphs and statistical analysis were done
using GraphPad Prism (Version 6.01; GraphPad Software, Inc.,
La Jolla, United States). Differences between and among groups
were analyzed by Student’s t-test, One-way ANOVA with Sidak’s
multiple comparison test or Two-way ANOVA with Holm-Sidak
multiple comparison test.
FIGURE 2 | (A) Residual nuclei. Fluorescence overlay on brightfield. (B) DNA quantification. **p < 0.01. The dotted line represents the maximum accepted DNA
concentration for decellularized tissues. Data derived from three independent experiments.
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FIGURE 3 | Histological analysis. (A) H&E staining of the native and decellularized left ventricle, mitral valve, and aorta tissues. (B) Movat’s pentachrome stain of the
native and decellularized left ventricle, mitral valve, and aorta tissues; muscle in dark red, collagen and reticular fibers in yellow, nuclei and elastin fibers in black, GAGs
in blue, and fibrin in bright red.
RESULTS
Decellularization of Cardiac Tissue
Efficiently Removed Cellular Constituents
and Maintained Extracellular Matrix
Structure and Components
Porcine cardiac components i.e., left ventricle, mitral valves, and
aorta were subjected to a rigorous decellularization procedure to
generate cell-free extracellular matrix (dECM). The presence of
remaining DNA in the decellularized ECM was assessed both by
detection of nuclei with DAPI and by quantification of residual
genomic DNA. For all three tissues, only rare disperse nuclei
could be detected after decellularization (Figure 2A). The same
finding was corroborated in Hematoxylin/Eosin-stained sections
(Figure 3A) and Movat’s Pentachrome stainings (Figure 3B).
Genomic DNA quantification showed a near 99% reduction
(Figure 2B, n= 3), in all three types of ECM compared to native
tissue. The dECMs contained<50 ng/mg of DNA per dry weight,
the standard maximal value for decellularized tissues (Crapo
et al., 2011).
Hematoxylin/Eosin (Figure 3A) and Movat’s pentachrome
(Figure 3B) stained sections showed that the ECM organization
was unaffected i.e., comparable to controls (native tissue,
Figure 3). The original tissues, and consequently the dECM,
presented diverse GAG content: mitral valves contained little
more than 30 µg/mg of GAGs, aorta about 20 µg/mg and left
ventricular myocardium about 15µg/mg. The final percentage of
GAGs content in the dECM was more than fifty percent of that
present in the original tissue for all the three tissues (Figure 4).
FIGURE 4 | GAG quantification in the native and decellularized left ventricle,
mitral valve, and aorta tissues (µg/mg of dry weight). *p < 0.05 and **p <
0.01. Data derived from three independent experiments.
Decellularized Cardiovascular Tissues
Differ in Protein Composition
The protein composition of the extracellular matrix from the
three cardiovascular tissues (left ventricle, mitral valve, and aorta)
was investigated with mass spectrometry. A total of 64 different
ECM proteins was identified and their spectral percentage i.e.,
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 7 May 2020 | Volume 8 | Article 520
Liguori et al. Tissue-Specific Hydrogels Drive Cell Plasticity
FIGURE 5 | Mass spectrometry analysis. Relative protein abundance (% of ECM spectra). The sum of the parts may be less than or greater than 100% because this
graphical representation takes into account only the mean values, without standard deviations. Data derived from three independent experiments.
the proportional number of molecules of each ECM protein in
the samples is given in Table S1. A summary of the results is in
Figure 5.
The proteomics analyses (n = 3) showed that all three tissues
contained collagens as their main ECM component, representing
around 76% of left ventricle dECM, 56% of mitral valve dECM,
and 37% of aortic dECM. The detailed distribution of the 64
proteins, including collagen types, is described in Table S1.
When different types and isoforms of collagens were analyzed
separately, it was demonstrated that ventricular ECM presented
higher amounts of collagen III alpha-1 chain, collagen IV alpha-1
chain, collagen IV alpha-2 chain, and collagen VI alpha-2 chain
when compared to both valvar and aortic ECM. A significant
difference was also demonstrated for collagen VI alpha-3 chain,
such as it was more expressed in the valvar ECM, corresponding
to the main ECM protein in this tissue. Elastin, in turn, was
found in expressive quantity in the aortic tissue (∼15%), but
not in the other two cardiovascular ECM, in which it was
found only in scanty amounts (<1%). Another fibrillar ECM
protein found in mass spectrometry analysis was fibronectin,
representing between 2.7 and 4.1% of all the ECM proteins for
all the three tissues, without significant differences among them.
Laminins, a basement membrane constituent, were found in a
less expressive, but still representative, amount. The ventricular
ECM was the one presenting the higher quantity of laminins
(5%), while the valvar ECM was the one presenting the less
amount (0.4%), with an intermediate percentage for the aortic
dECM (2.5%). The analysis of different isoforms of laminins
showed significant differences for laminin subunit alpha-2 and
for laminin subunit gamma-1, such as these isoforms were more
expressed in the ventricle ECM than in the other cardiovascular
tissues. Perlecan, another basement membrane constituent,
was also found in a significant higher amount in ventricular
(10%) and aortic (7.3%) ECM, when compared to the valvar
(1.5%) ECM. Other main proteoglycans found in the three
cardiovascular ECM were versican and biglycan. Versican was
found in similar amounts in both the valvar (7.3%) and aortic
(8.6%) ECM, but interestingly not found in the ventricular ECM.
Finally, biglycan (a TGF-β co-receptor) was significantly more
expressed in the aortic (5.7%) ECM than in the other two
cardiovascular tissues, representing around 1% for the ventricle
and mitral valve dECM.
Other ECM proteins found were fibulins, periostin, cartilage
intermediate layer protein 2 (CILP-2), elastin microfibril
interfacer 1 (EMILIN-1), latent-TGF-β-binding protein, and
lysyl oxidase. Fibulins represented an important amount of the
proteins found in cardiovascular ECM, particularly in the aortic
tissue. The three types of fibulins found in mass spectrometry
were fibulin-1, fibulin-2, and fibulin-5, such as the first two
were found in lesser amount—and in similar distribution among
the tissues—than the last. Fibulin-5, in turn, was expressed in
a significantly higher amount in the aortic tissue (6.9%) when
compared to both other cardiovascular ECM (<2% for both).
Periostin was found in considerable amounts (8.2%) in the valvar
ECM, but was almost non-existent in the other two ECM (<1%),
although this difference did not reach statistical significance.
CILP-2 was found in considerable quantity in the valvar tissue
(3.7%), but not in ventricular or aortic ECM. EMILIN-1, a
glycoprotein responsible for the interface between elastin and
microfibrils, was only found in the aortic ECM, similarly to lysyl
oxidase, an extracellular copper-dependent enzyme responsible
for the cross-linking between collagen and elastin (and also
between collagen fibers), which was found in greater amount in
the aortic ECM (1.4%). Finally, latent-TGF-β-binding protein,
which regulates TGF-β bioavailability, was also only found in the
aortic ECM.
Hydrogels Derived From the Left Ventricle,
Mitral Valve, and Aorta dECM Vary in
Structural Morphology and Mechanical
Properties
Scanning electron microscopy (SEM) demonstrated that
the three hydrogels present considerably different structural
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FIGURE 6 | Scanning electron microscopy of the left ventricular, mitral valve, and aortic dECM hydrogels.
FIGURE 7 | Stress vs. strain curves measured at a strain rate of 0.2 s−1 for the three hydrogels at different concentrations: (A) ventricle hydrogel, (B) mitral valve
hydrogel, and (C) aorta hydrogel. (D) Hydrogels stiffness of the three hydrogels in different concentrations. ***p = 0.0001. Data derived from three
independent experiments.
morphology (Figure 6). The ventricle-derived hydrogel showed
a pattern resembling a dense grouping of plate-like structures.
Aorta-derived hydrogels, in turn, exhibited a network of
honeycomb-like pores. Finally, mitral valve-derived hydrogels
displayed another distinct pattern, with millefeuille-like sheets of
extracellular matrix allocated in several very thin layers.
The stress vs. strain curves for the hydrogels derived from
the three cardiovascular dECM were plotted for hydrogels
with 5, 10, and 20 mg/mL dECM concentration and stiffness
was calculated as the slope of the stress vs. strain curve
(Figure 7, Table 1, n = 3). The stiffness increased, for all tissues,
with the increase of ECM concentration (Two-way ANOVA,
concentration factor, p < 0.0001). For 5 and 10 mg/mL ECM
concentrations, no statistically significant differences were found
among the hydrogels. For 20 mg/mL ECM concentration,
however, hydrogels derived from aortic ECM proved to be
significantly stiffer than both the ventricular and valvar hydrogels
(Two-way ANOVA, hydrogel factor, p = 0.0002; Holm-Sidak
multiple comparison test: left ventricle vs. aorta p = 0.0001,
mitral valve vs. aorta p= 0.0001).
The stress relaxation over time was plotted and the generalized
Maxwell model was fitted to the data. Each hydrogel was
described according to their relaxation time constants (t), spring
constants (Ei), and relative importance (Figure 8, Table 1, n
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TABLE 1 | Mechanical properties of the three different hydrogels.




5 10 20 5 10 20 5 10 20
Stiffness
(Pa)
325 ± 149 1473 ± 663 3384 ± 698 289 ± 222 1386 ± 1039 3233 ± 323 792 ± 75 2942 ± 1755 6998 ± 895
VISCOELASTICITY
Element E1 E2 E3 E4 E1 E2 E3 E1 E2 E3
T(s) 0.24 ± 0.02 1.96 ± 0.06 13.16 ± 0.49 198.50 ± 31.16 0.23 ± 0.02 2.56 ± 0.33 27.12 ± 11.70 0.26 ± 0.11 2.47 ± 1.13 25.22 ± 18.02
Ei 1169 ± 163 689 ± 140 508 ± 119 822 ± 202 1417 ± 222 567 ± 149 683 ± 142 4814 ± 995 1131 ± 608 671 ± 218
RI (%) 36.9 ± 2.6 21.5 ± 0.4 16.1 ± 1.1 25.5 ± 1.5 60.6 ± 12.1 23.5 ± 1.3 23.9 ± 5.5 74.9 ± 10.4 17.6 ± 8.9 11.2 ± 4.5
τ , relaxation time constant; Ei , spring constant; RI, relative importance.
= 3). The stress relaxation curves showed that left ventricular
hydrogels started with a low stress value, but kept higher residual
stress, while the aortic hydrogels started with a higher stress value
and presented an important relaxation, reaching zero within
the 100 s of follow-up. Mitral valve hydrogels, in turn, started
with low stress values, relaxed quickly reaching zero within the
100 s. This indicates that ventricular hydrogel behaved more like
viscoelastic solid, whereas the aorta and valvar hydrogel like a
viscoelastic liquid.
Left ventricle hydrogel resolved in four Maxwell elements,
while mitral valve and aortic hydrogels resolved in three Maxwell
elements to fit to measured stress relaxation. For all the three
hydrogels, the first Maxwell element presented the highest
impact, representing around 37, 51, and 76% of the relaxation
in, respectively, the ventricular, valvar, and aortic hydrogels.
The relative importance of the second Maxwell element varied
between 18 and 23% among the hydrogels, while these values
were between 11 and 24% for the third Maxwell element.
The fourth Maxwell element represented a significant relative
importance for the ventricular hydrogels, of around 26%. The
Maxwell elements, for all hydrogels, were defined according to
their t values. The first Maxwell element showed different Ei
and relative importance (RIi) values among the hydrogels. Ei
values were higher for the aortic hydrogel when compared to
both the left ventricular and mitral valve hydrogels (One-way
ANOVA, p = 0.0005; Holm-Sidak multiple comparison test:
left ventricle vs. aorta p = 0.0009, mitral valve vs. aorta p =
0.0009). The firstMaxwell element had a stronger impact in aortic
hydrogels compared to left ventricle hydrogels, with the valvar
hydrogels showing a relative importance value in between (One-
way ANOVA, p= 0.0087; Holm-Sidak multiple comparison test:
left ventricle vs. aorta p = 0.0093, left ventricle vs. mitral valve
p = 0.0492). The Ei or RIi of the second and the third Maxwell
element did not differ.
Hydrogels Derived From the Left Ventricle,
Mitral Valve, and Aorta dECM Differ in
Bioactivity
After 7 days of culture, ASCs had formed confluent monolayers
on tissue culture plastic (TCP), and on the left ventricle and
aortic dECM hydrogels (Figures 7A,B,D). In these cases, the
ASC had actin filaments throughout their cytoplasm. On mitral
valve dECM hydrogel, ASCs had aggregated and formed long
cytoplasmic protrusions (Figure 9C, arrows).
Our earlier research showed that TGF-β1 stimulation
efficiently differentiates ASCs into smooth muscle cells (SMC).
Seven days of TGF-β1 stimulation, on TCP indeed differentiated
ASC in SM22α-expressing SMC (Figure 10, n = 3), while
only few ASC normally expressed SM22α. In contrast, TGF-
β1 stimulation of ASCs on left ventricular dECM hydrogels
differentiated the cells when compared to non-induced ASC, but
appeared to be blocked when compared to SMC differentiation
in TCP, as evidenced by the reduced expression of SM22α (One-
way ANOVA, p = 0.0001; Holm-Sidak multiple comparison
test: TCP + TGF-β1 vs. left ventricle + TGF-β1 p = 0.0108).
Similarly, on mitral valve dECM hydrogels, TGF-β1-induced
SMC differentiation of ASCs was also blocked and SM22α
expression was reduced when compared to cells induced in
TCP (One-way ANOVA, p = 0.0001; Holm-Sidak multiple
comparison test: TCP + TGF-β1 vs. mitral valve + TGF-
β1 p = 0.0400). In contrast, non-induced ASC differentiated
to SMC on aortic dECM hydrogels (One-way ANOVA, p <
0.0001; Holm-Sidak multiple comparison test: TCP vs. aorta
p < 0.0001). The additional stimulation with TGF-β1 had no
measurable influence.
Left Ventricular, Mitral Valve, and Aortic
dEMC Hydrogels Differentially Influence
VNF
Vascular network formation was evaluated in 3D by confocal
microscopy in the three different hydrogels. After 7 days
of co-culturing ASC and HPMEC (1:2) inside dECM
hydrogels, VNF had occurred in the left ventricle, mitral
valve and aortic hydrogels (Figure 11) albeit that the network
morphologies differed. In left ventricle dECM hydrogels,
vascular structures appeared to be both thicker and longer
(Figure 11, red arrows) compared to both other hydrogels. In
mitral valve and aortic dECM hydrogels, vascular structures
were fewer and smaller (Figure 11). In all three gels, large
aggregates of cells had formed as observed by nuclear staining
with DAPI.
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FIGURE 8 | Stress relaxation behavior of 20 mg/ml hydrogels and the average Maxwell model fitting output. (A) Hydrogels stress relaxation curves and their
respective averaged Maxwell model equations. Relaxation time constants (t), spring constants (Ei ), and relative importances (RI) are shown for the first (B,F,J), second
(C,G,K), third (D,H,L), and fourth (E,I,M) Maxwell elements. *p < 0.05 and **p < 0.01. Data derived from three independent experiments.
DISCUSSION
The main results of our investigations are that we optimized
a procedure to reproducibly and reliably generate extracellular
matrix hydrogels from decellularized, highly different cardiac
components i.e., left ventricle, mitral valve, and aorta. We show
that the left ventricle, mitral valve, and aorta dECM hydrogels
differ in largely molecular composition, mechanical properties
and bioactivity (Table 2). The major findings were that left
ventricle dECM hydrogels (1) contained the highest content
of basement membrane constituents; (2) had viscoelasticity
comprising four Maxwell elements and around 3 kPa stiffness
(20 mg/mL gel), (3) suppressed ASC differentiation, but (4)
augmented VNF. Mitral valve dECM hydrogels, on the other
hand, had (1) periostin as a major constituent; (2) a lower
viscoelastic complexity (three elements) and also around 3 kPa
stiffness (20 mg/mL gel); (3) suppressed ASC differentiation,
and (4) had marginal VNF support. Finally, aortic dECM
hydrogels differed from both others and (1) had the highest
content of non-collagen constituents i.e., elastin, fibulins, and
biglycan to mention a few; (2) a viscoelasticity of three elements
with high stiffness, around 7 kPa (20 mg/mL gel); (3) caused
non-induced ASC differentiation to SMC; and (4) marginally
supported VNF.
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FIGURE 9 | ASC cultured for 7 days on top of tissue culture plastic (TCP), left ventricular, mitral valve, and aortic dECM hydrogels stained for phalloidin. (A) TCP, (B)
ventricle, (C) mitral valve, and (D) aorta.
FIGURE 10 | ASC myogenic differentiation on the hydrogels (concentration: 20 mg/mL). (A) SM22α staining. (B) Quantification of SM22α expression. *p < 0.05 and
**p < 0.01. Data derived from three independent experiments.
FIGURE 11 | 3D vascular networking formation in the three different dECMs hydrogels. Stacked 3D image reconstruction of 50µm sections. Blue, nuclei; green,
HPMEC; red, ASC. Red arrows point to the vessel-like structures within each micrograph.
These biochemical and biomechanical differences among the
three different cardiovascular tissue-derived hydrogels correlates
to the differences found in the physiological situation, i.e.,
the biochemical and biomechanical properties of the respective
tissues. These differences, as shown in the present work, directly
impact cell behavior and, thus, are of great relevance because
they can be used to mimic the in vivo microenvironment
during in vitro studies. In fact, the use of such tissue-specific
microenvironments for tissue engineering has been proposed
to reduce the use of animal models during drug development
and pathophysiological studies, besides tissue-engineering for
therapeutic purposes (Liguori et al., 2017).
Molecular Clues
In regard to the molecular clues, the first to be noted is the
differences in GAG content. GAG are responsible for the binding
of several growth factors that can stimulate cell response—
such as fibroblast growth factors (FGF), hepatocyte growth
factor (HGF)—chemokines as interleukins, enzymes (and their
inhibitors), as well as several ECMproteins including fibronectin,
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TABLE 2 | Molecular and biomechanical differences among ECM from different
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↑Greater expression/value than the other two dECM.
↓Lower expression/value than the other two dECM.
laminin, and type V collagen (Varki et al., 1999; Esko et al., 2017).
Although in ventricular tissue the reduced GAG content followed
the reduced content of the versican core protein, in valvar
tissue GAG expression was increased compared to the other
matrices besides the reduced content of the perlecan core protein.
This shows that not only GAG content may vary among the
matrices, but also the types of proteoglycans which are present in
different tissues, which might influence how these GAGs interact
with the cells. Previously, it was shown that extrinsic perlecan
suppressed adipogenic and promoted osteogenic differentiation
in bone marrowmesenchymal stem cells (Nakamura et al., 2014).
Although the influence of perlecan on myogenic differentiation
was never investigated, it is known that this proteoglycan
binds the latent form of TGF-β, increasing the growth factor
bioavailability (Chen et al., 2007; Sengle et al., 2011). Versican,
in turn, facilitates chondrocyte differentiation in vivo by binding
to TGF-β and fixating it to the ECM, thus, favoring TGF-
β signaling pathways in the surrounding cells (Choocheep
et al., 2010). In vitro, versican was shown to induce myogenic
differentiation of fibroblasts by increasing active TGF-β signaling
(Carthy et al., 2015).
The second difference in the molecular composition of the
ECM refers to the increased presence of collagens type III, IV,
and VI in the ventricular tissue when compared to the valvar
and arterial matrices. The absence of type III collagen was shown
to be responsible for the myofibroblast differentiation in a mice
model, suggesting that this type of collagen plays an important
role in maintaining the fibroblastic phenotype (Volk et al., 2011).
Interestingly, collagen VI—which was increased in both the
ventricular and valvar matrices—was shown to be responsible
for cardiac fibroblast differentiation into myofibroblasts in vitro
(Naugle et al., 2006). Paradoxically, collagen VI was also shown
to enhance MSC expansion while maintaining the stem cell
phenotype (Smeriglio et al., 2017). One of the reasons why
collagen VI seems to be involved in cell fate might be related
to the biophysical modulation of the environment—either in
the native ECM or in a hydrogel—since it was shown that
collagen VI is crucial for the biomechanical integrity of the
pericellular matrix in MSC (Twomey et al., 2014) and also that
soluble fragments of collagen VI can mediate stimulation of
DNA synthesis via tyrosine phosphorylation of paxillin, FAK, and
p130CAS—proteins that associate with focal adhesions—in the
absence of classical growth factors (Rühl et al., 1999).
Laminin family was another group of proteins which was
differentially expressed among the matrices. Ventricular ECM
presented increased levels of laminin subunit alpha-2 and
laminin subunit gamma-1 when compared to the other two ECM
types. Laminins have been shown to suppress chondrogenic,
but to induce osteogenic differentiation of mesenchymal stem
cells, contributing to bone tissue development, through an
ERK-dependent pathway (Klees et al., 2005, 2008; Hashimoto
et al., 2006; Mittag et al., 2012). Other effects of laminins
on mesenchymal stem cells related to ERK pathways are the
differentiation into insulin-producing cells (Lin et al., 2010),
and the promotion of neurite outgrowth (Mruthyunjaya et al.,
2010). In regard to myogenic differentiation, laminin-2 has
been suggested to induces smooth muscle myogenesis by down-
regulation of RhoA, but no other studies investigated the effect of
laminins on myogenic differentiation (Beqaj et al., 2002). Herein,
we did not find the expected myogenic differentiation supposedly
promoted by laminins, in fact, the opposite was demonstrated.
This might be related to the fact that several other factors were
acting on the ASC and the strength of laminin influence was not
enough to exercise any effect. On the other hand, laminin was
shown to promote 3D vascular network formation in collagen
scaffolds by regulating VEGF uptake (Stamati et al., 2014), what
corroborates our findings. We demonstrated that ventricular
dECM-derived hydrogel, which present higher laminin content
than the other two matrices, was also the one showing better 3D
vascular network formation.
Mitral valve extracellular matrix showed increased protein
expression of cartilage intermediate layer protein 2 (CILP-2),
which was absent in both other tissues, although cartilage
intermediate layer protein 1 (CILP-1) was present in both the
ventricular and valvar matrices. This is an interesting finding
that coincides with the behavior of the adipose stromal cells
in regard to differentiation upon TGF-β1 stimulation. Cartilage
intermediate layer protein is a large secreted glycoprotein and
its CILP-1 form has been shown to block TGF-β1 activity
through direct interaction with TGF-β1 and inhibition of TGF-β1
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signaling (Seki et al., 2005; van Nieuwenhoven et al., 2017; Zhang
et al., 2018). Although there are no studies in regard to the CILP-
2 interaction with TGF-β1, it may probably present a similar
behavior to CILP-1.
The aortic dECM hydrogels, in turn, showed a series of
proteins significantly higher expressed compared to the two other
matrices, all of them being proteins constituents of elastic fibers.
One of them was biglycan, a proteoglycan that forms complexes
with collagen and elastic fibers components and binds to TGF-β1
(Hildebrand et al., 1994; Reinboth et al., 2002). This, per se, might
justify the contribution of the aortic matrix to the non-induced
myogenic differentiation of ASC. In fact, the use of the word
non-induced was preferred over spontaneous because it is known
FBS-containing culture medium contains 1–2 ng/mL of TGF-β1
(Danielpour et al., 1989; Oida and Weiner, 2010). Thus, what
might actually be in course is the binding of serum-derived TGF-
β1 to the hydrogel and, consequently, its presentation to the cells
in a higher concentration than that found in the culture medium.
Another protein highly expressed in aortic ECM was elastin
microfibril interfacer 1 (EMILIN-1), a protein responsible for the
formation of the elastic fiber and for cell anchoring. EMILIN-
1 has been shown to inhibit TGF-β signaling in vivo (Zanetti
et al., 2004; Zacchigna et al., 2006), what could be understood
as paradoxical to our findings. However, it was demonstrated
that the mechanism of TGF-β signaling inhibition by EMILIN-
1 occurs through the binding with the precursors of TGF-β
(proTGF-β), not allowing it to be converted into mature TGF-
β (Zacchigna et al., 2006). A third protein which was more
abundantly present in the aortic matrix was fibulin-5. Fibulin-
5 is an ECM protein crucial for elastogenesis and also able to
promote elastic fiber organization (Hirai et al., 2007). The role of
fibulin-5 is closely related to the fact this protein contains several
Arg-Gly-Asp (RGD)motifs (Albig and Schiemann, 2005), besides
also presenting calcium-binding EGF-like domains (Timpl et al.,
2003). While the RGD motifs bind the integrins of cells, the
calcium-binding EGF-like domains of fibulin-5 were shown to
bind latent TGF-β-binding protein 2 (LTBP-2) (Hirai et al., 2007),
another protein we found in significantly higher levels in the
aortic matrix. The LTBP-2, in turn, plays an important role in
TGF-β availability in the cell microenvironment by the binding
latent form of TGF-β which is, then, cleaved by proteases into
mature TGF-β (Robertson et al., 2015). Since ASC produce TGF-
β (Rehman et al., 2004; Du et al., 2016), released in the latent
form, LTBP-2 may increase TGF-β availability by binding the
latent TGF-β in the ECM, not allowing it to be diluted in the
medium and, then, also increasing the concentration of the
growth factor available to the cells. Finally, the last protein found
to be overexpressed in the aortic matrix, when compared to
the ventricular and mitral matrices, was lysyl oxidase (LOX), an
enzyme that initiates the crosslinking in collagen and elastin.
LOX is known to both bind TGF-β (Atsawasuwan et al., 2008),
but also to have its expression upregulated by the growth factor
(Gacheru et al., 1997; Shanley et al., 1997).
Biomechanical Clues
Besides the different molecular clues given by the three
different matrices, we also investigated the influence of their
biomechanical properties, which differs for each matrix and
may play a role in cell behavior. In summary, the two main
findings in this regard were a significantly higher stiffness found
in the hydrogels derived from aortic dECM and viscoelastic
solid nature of hydrogels derived from ventricular dECM, which
is also manifested as a higher number of Maxwell elements.
Stiffness is known to influence cell behavior, including cell
differentiation and microvascular network formation, being
extensively discussed in literature (Engler et al., 2006; Even-
Ram et al., 2006; Wells, 2008; Califano and Reinhart-King,
2009; Park et al., 2011; Schaap-Oziemlak et al., 2014; Ye et al.,
2015; Mao et al., 2016). Viscoelasticity, on the other hand, is a
combination of influencing factors much less debated. In general,
authors treat their hydrogel materials as elastic when, in fact,
they are viscoelastic due to large water content. This means that,
besides elasticity, which is generally represented by stiffness, these
materials present another important biomechanical property
which is viscoelasticity, represented by stress relaxation.
Hydrogels with specific stiffnesses were previously shown to
promote mesenchymal stem cells differentiation into smooth
muscle cells under TGF-β induction, although non-induced
differentiation was not described (Park et al., 2011). In fact,
stiffnesses ranging between 8 and 17 kPa are considered to
promote myogenic differentiation (Engler et al., 2006), which is
very close to our findings for the hydrogels derived from aortic
dECM (6.9 ± 0.8 kPa). This might be a contributing factor
for the behavior of ASC cultured on aortic dECM hydrogels,
particularly when taken together with the previously discussed
biomolecular clues found in this matrix. Hydrogels constituted
of pure collagen exhibit lower stiffness values in comparison to
dECM hydrogels, ranging from 30 Pa for 3 mg/mL to 1.8 kPa
for 20 mg/mL (Cross et al., 2010). This difference might be
related to the combination of collagen fibers with other ECM
proteins, such as elastin, present in dECM hydrogels, which
importantly improve their elastic modulus. In regard to vascular
network formation, literature is limited but it has been shown
that soft substrates facilitate endothelial cell network assembly
(Califano and Reinhart-King, 2008, 2009), which corroborates
with our findings.
In regard to the stress relaxation, to the best of our knowledge
there is no more than a handful of studies in literature describing
the effects of stress relaxation on cell behavior, particularly
regarding cell spreading (Cameron et al., 2011; McKinnon
et al., 2013; Chaudhuri et al., 2015, 2016; Bauer et al., 2017;
Charrier et al., 2018), proliferation (Cameron et al., 2011;
Chaudhuri et al., 2016; Bauer et al., 2017), and differentiation
(Cameron et al., 2011, 2014; Chaudhuri et al., 2016; Charrier
et al., 2018). Unfortunately, the order of magnitude in stress
relaxation varies among the studies, from t1/2 (time until 50%
relaxation) starting at 60 s (Chaudhuri et al., 2016) until t1/2
of more than 30,000min (Cameron et al., 2011). Chaudhuri
et al. demonstrated that while osteogenic differentiation requires
fast-relaxing hydrogels (optimal when t1/2 = 60 s), adipogenic
differentiation requires slow-relaxing hydrogels (optimal when
50% relaxation t1/2 = 2,300 s) (Chaudhuri et al., 2016). Probably,
myogenic differentiationwould require a relaxation time between
these two. Although Cameron et al. showed improved myogenic
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differentiation in hydrogels presenting t1/2 = 250min (15,000 s)
when compared to hydrogels with even higher t1/2 (up to over
30,000min) (Cameron et al., 2011), they also showed that both
adipogenic and osteogenic differentiation were increased in these
hydrogels with lower t1/2 values, what lead to questioning if the
range of stress relaxation time used by the authors was not much
above the ideal for cell culturing. The stress relaxation in our
hydrogels, in contrast, was even faster than those reported by
Chaudhuri et al., for all the three different matrices, with t1/2
lower than 1 s.
Another difference between the studies was the stiffness
of these hydrogels. Although both authors kept the stiffness
constant within their experiments, Chaudhuri et al. used
hydrogels with 9 and 17 kPa (Chaudhuri et al., 2016), while
Cameron et al. used hydrogels of 4.7 kPa (Cameron et al., 2011).
Thus, there is also the combinatory effect of stiffness and stress
relaxation, which is the whole point of the viscoelasticity theory.
In our study, for instance, stiffness was not controlled, so that
hydrogels could present high values of stiffness while presenting
low stress relaxation time (aorta), low values of stiffness with also
low stress relaxation time (mitral valve), or low values of stiffness
with high stress relaxation times (left ventricle). This points to the
need for a more robust descriptive reference for viscoelasticity
than only looking at stiffness and stress relaxation separately,
which we believe to be the Maxwell elements. As previously
mentioned, these elements allow the dissection of several main
components exerting the resistive forces during and after strain.
In the present study, we showed that the hydrogels
derived from ventricular dECM, which led to the inhibition
of ASC differentiation but supported the growth of robust
and interconnected vascular networks in 3D, presented an
extra Maxwell element. To define what component is being
represented by each Maxwell element is a difficult task in natural
materials (Peterson et al., 2013), particularly because it is not
possible to control the components present in these materials.
It is, however, well accepted that the first element, which tends
to present a t-value smaller than 1s, represents water and soluble
small molecules (Bausch et al., 1999; Cense et al., 2006; Peterson
et al., 2013). The second element, with a t-value between 1s and
10s, could represent glycosaminoglycans, small proteoglycans,
and other small ECM proteins (e.g., biglycan, EMILIN-1, fibulin-
5) and water bound to GAGs and other hygroscopic molecules,
while the third, with a t-value between 10s and 100s, could
be large extracellular matrix proteins (e.g., fibrillar collagens,
versican, perlecan, laminin). Finally, the fourth Maxwell element,
which was only present in the hydrogels derived from ventricular
dECM, should then be related to some component either only
present in the ventricular ECM or at least increased in this matrix
when compared to the other two. Thus, considering the increased
expression and the percentual protein content in the ventricular
ECM (see Table S1), the fourth Maxwell element should be
collagen IV.
Differently from fibrillar collagens (e.g., collagens type I, II,
and III), collagen IV is network-forming collagen (Muiznieks and
Keeley, 2013). It was previously shown that while crosslinked
meshes of synthetic polymers increase the time required for
stress relaxation, linear chains lead to faster stress relaxation
(Chaudhuri et al., 2016; Charrier et al., 2018). This behavior
found in synthetic polymers could also explain the findings of
our study so that the crosslinked meshes of collagen IV are
leading to the prolonged time necessary for stress relaxation.
To date, no other study investigated the effect of viscoelasticity
on cell differentiation or vascular network formation under the
lens of Maxwell elements, so that the present work is the first
to do so. Previous authors, however, hypothesized on how the
viscosity i.e., stress relaxation may influence cell behavior. In our
opinion, the next step is relating cell behavior to the strength and
relaxation time constants of individual Maxwell elements, which
are in turn related to the hydrogel composition. Briefly, while in
elastic matrices the forces exerted by the cell on the matrix (and
consequently by the matrix on the cell) are kept constant over
time, in viscoelastic materials the matrix relaxes over time so that
the forces are decreased and the matrix is remodeled (Chaudhuri
et al., 2016). Faster relaxation i.e., faster matrix remodeling would
lead to increased RGD-ligand clustering, cell shape change,
proliferation, and differentiation stimuli (Chaudhuri et al., 2016).
LIMITATIONS
A limitation of the study is the use of CTCF, i.e., fluorescence
intensity, to quantify the myogenic markers. Ideally, the
quantification of the number of cells expressing the marker
would be a preferable alternative. However, the fact that, as
demonstrated in Figure 9, the mitral valve hydrogel tended to
lead cells to form clusters, precludes running a cell to cell analysis.
CONCLUSION
The three main cardiovascular tissues (myocardium, valves,
and vessels) can be used to fabricate hydrogels from dECM.
Different tissues, however, can lead to different cell behavior,
in regard to differentiation and vascular network formation, by
combining different molecular and biomechanical clues. Our
results motivate further studies on how hydrogels derived from
different matrices (beyond cardiovascular tissue) can guide the
behavior of different cell types.
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